190 related articles for article (PubMed ID: 12747140)
1. Managing the cost drivers of medical injectables.
Johnson KA
Manag Care Interface; 2003 Apr; 16(4):37-40. PubMed ID: 12747140
[TBL] [Abstract][Full Text] [Related]
2. Helping to manage the high cost of rare diseases.
Hesselgrave BL
Manag Care Q; 2003; 11(1):1-6. PubMed ID: 12790059
[TBL] [Abstract][Full Text] [Related]
3. Specialty pharmaceuticals: developing a management plan.
Willcutts D
Manag Care Q; 2002; 10(4):26-9. PubMed ID: 12561391
[TBL] [Abstract][Full Text] [Related]
4. Designing and implementing an effective specialty pharmacy service program.
Morrow TJ
Manag Care Interface; 2003 Apr; 16(4):50-3. PubMed ID: 12747141
[TBL] [Abstract][Full Text] [Related]
5. Cap for injectables not for the faint of heart.
Capitation Rates Data; 2003 Jul; 8(7):79-81. PubMed ID: 12908211
[No Abstract] [Full Text] [Related]
6. Strategies for managing injectable drugs in a managed care setting.
Tercero W
Manag Care Q; 2002; 10(3):16-20. PubMed ID: 12476661
[TBL] [Abstract][Full Text] [Related]
7. Control your exposure for costs of injectables, biologics.
Capitation Rates Data; 2002 Dec; 7(12):137-8. PubMed ID: 12506731
[No Abstract] [Full Text] [Related]
8. The role of the PBM in total health management strategies for individuals with chronic conditions.
Slezak J; Stine N
Benefits Q; 2003; 19(1):38-44. PubMed ID: 12608117
[TBL] [Abstract][Full Text] [Related]
9. A behind-the-numbers look at rising Rx costs.
McCarthy R
Bus Health; 1998 Feb; 16(2):29, 32-5. PubMed ID: 10177023
[TBL] [Abstract][Full Text] [Related]
10. Controlling the cost of branded drugs.
Mandelker J
Bus Health; 1993 Nov; 11(13):44-6, 48. PubMed ID: 10130506
[TBL] [Abstract][Full Text] [Related]
11. Managing drugs for rare genetic diseases: trends and insights.
Zitter M
Manag Care; 2005 Feb; 14(2):52-4, 57-60, 63-4; quiz 66-7. PubMed ID: 15782848
[TBL] [Abstract][Full Text] [Related]
12. The metamorphosis of chronic care. Managed care and chronic care.
Halvorson GC
Healthc Forum J; 1998; 41(5):28-30. PubMed ID: 10185481
[No Abstract] [Full Text] [Related]
13. Managing chronic disease.
Mandelker J
Bus Health; 1994 Nov; 12(11):45, 49-50. PubMed ID: 10138535
[No Abstract] [Full Text] [Related]
14. The evolving pharmacy benefit market.
Navarro RP
Med Interface; 1994 May; 7(5):65-7, 70. PubMed ID: 10134345
[TBL] [Abstract][Full Text] [Related]
15. DM vendors start to address costs created by comorbidities.
Carroll J
Manag Care; 2002 Mar; 11(3):42A-42B, 42E. PubMed ID: 11928243
[No Abstract] [Full Text] [Related]
16. Study maintains MCOs need redesign to meet challenge of managing chronic illness.
Healthc Demand Dis Manag; 1997 Aug; 3(8):125-7. PubMed ID: 10175571
[No Abstract] [Full Text] [Related]
17. The Pharmaceutical Management Panel - highlights of the pharmacy business.
Kirshenbaum D
Dis Manag; 2003; 6(Suppl 1):S15-7. PubMed ID: 14751024
[No Abstract] [Full Text] [Related]
18. Leading employers share strategies for managing promising, high-cost biotech medications.
Hom D; Mahoney J; Wells KD; Lednar WM
Am J Manag Care; 2008 Jul; 14(8 Suppl):S264-8. PubMed ID: 18672957
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical industry and payer partnerships to manage costs and improve quality.
Mauch RP
Manag Care; 2001 Sep; 10(9 Suppl):2-4; discussion 9-12. PubMed ID: 11729438
[No Abstract] [Full Text] [Related]
20. Managed care rebound? Recent changes in health plans' cost containment strategies.
Mays GP; Claxton G; White J
Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-427-36. PubMed ID: 15451964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
